Alltrna, a Flagship Pioneering company unlocking transfer RNA (tRNA) biology and pioneering tRNA therapeutics to regulate the ...

More than 60 years after its discovery, scientists are still learning surprising ways DNA stores and translates instructions ...

University of Cambridge spin-out Semarion has secured $3.8 million funding in a round led by Parkwalk, and joined by The FSE ...

UK biotech Semarion has secured $3.8 million (£2.9 million) to expand manufacturing and commercial reach of its cell-based ...

Semarion, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell ...

Patients with this genetic disorder have a form of dwarfism — they are short in stature and have underdeveloped ears and ...

Semarion has secured new funding to expand its cell-based drug discovery platform, supporting manufacturing scale-up, ...

A biotech spin-out from the University of Cambridge has secured £2.9m to scale its cell assay technology and remove bottlenecks in cell screening.

Scientists have engineered a tobacco relative to produce five psychedelic tryptamines, compounds normally scattered across ...

Unlike bacteria or yeast, moss can produce large polypeptides of human collagen along with the post-translational modifications that make it stable and bioactive.

Stepping away from its billions-of-years-old role as a genetic blueprint, DNA is now embarking on a new journey as an active ...

A small but growing number of homeowners who want to tap into their home equity without making monthly payments are looking into home equity agreements. Also known as home equity investments (HEI) or ...